United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$41Mraised across 4 rounds since 2009, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Morningside Group
New Leaf Venture Partners
Summit PartnersNational Cancer Institute (NCI)Morningside Ventures
Kenson VenturesMissing a round, or an investor who was in one? Tell us.
Advanced Cell Diagnostics's investors include Morningside Group, New Leaf Venture Partners, Summit Partners, National Cancer Institute (NCI) and Morningside Ventures, and 1 more on record.
Advanced Cell Diagnostics has raised $41M across 4 rounds since 2009.
Advanced Cell Diagnostics's most recent round was a Series C of $22M in Jun 2015.
Its most recent round, $22M in Jun 2015, is also its largest on record.
Advanced Cell Diagnostics's first round on record, in Sept 2009, was backed by Morningside Group.
Advanced Cell Diagnostics's latest named round is a Series C, in Jun 2015.
Advanced Cell Diagnostics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
